Role of protease and protease inhibitors in cancer pathogenesis and treatment

Eatemadi, Ali and T. Aiyelabegana,, Hammed and Negahdari, Babak and Mazlomia, Mohammad Ali and Daraeeb, Hadis and Daraeeb, Nasim and Eatemadie, Razieh and Sadroddinya, Esmaeil (2017) Role of protease and protease inhibitors in cancer pathogenesis and treatment. 2016 Elsevier Masson SAS. All rights reserved, 86. pp. 221-231.

Preview

Text eatemadi2017.pdf Download (2MB) | Preview

Abstract

Cancer is the second cause of death in 2015, and it has been estimated to surpass heart diseases as the leading cause of death in the next few years. Several mechanisms are involved in cancer pathogenesis. Studies have indicated that proteases are also implicated in tumor growth and progression which is highly dependent on nutrient and oxygen supply. On the other hand, protease inhibitors could be considered as a potent strategy in cancer therapy. On the basis of the type of the key amino acid in the active site of the protease and the mechanism of peptide bond cleavage, proteases can be classified into six groups: cysteine, serine, threonine, glutamic acid, aspartate proteases, as well as matrix metalloproteases. In this review, we focus on the role of different types of proteases and protease inhibitors in cancer pathogenesis.

Actions (login required)

View Item